Navigation Links
Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
Date:1/7/2009

OXFORD, England, January 7 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy and critical care, today announced that following successful clinical results achieved in 2008 with its ToleroMune(R) anti-allergy technology, the company has now completed patient recruitment for a further phase II clinical trial in cat allergy. The study, which is underway in Canada, has recruited 120 patients with confirmed cat allergies, and all the participants have completed screening and initial dosing with none experiencing any significant adverse events or safety issues. Circassia anticipates completing patient dosing in the next three months, with follow-up post-treatment challenge visits being completed by the end of April 2009.

The double-blind, randomized, placebo-controlled study is comparing several different ToleroMune treatment regimens, each with standardised doses administered over several weeks. This is in sharp contrast to most current allergy immunotherapies, which can require carefully titrated dosing over many months and even years. As part of the ongoing study, each patient is exposed to cat allergens in a controlled environmental exposure chamber both before and after receiving the study treatment. During these "challenges" the volunteers will monitor and record their allergic rhinitis symptoms to allow investigators to assess the effect of the ToleroMune treatment.

"We are delighted that this trial is making such rapid progress as it should define the optimal treatment approach for our ToleroMune cat-allergy therapy as it moves towards phase III testing," said Steve Harris, Circassia's CEO. "We are commited to introducing our ToleroMune treatment for cat allergy as quickly as possible because, despite its prevalence, the condition is poorly served by existing therapies due to their aggressive side-effect profile. ToleroMune offers allergists and their patients sig
'/>"/>

SOURCE Circassia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
2. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
9. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Semler Scientific, Inc. (Nasdaq: SMLR ... manufactures and markets products that assist healthcare providers in ... results for the first quarter ended March 31, 2015. ... Semler reported continued progress with year over year growth ... of 14%," said Doug Murphy-Chutorian , M.D., chief ...
(Date:5/1/2015)... 2015  Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: ... following the results of the Phase 3 Rocket 1 ... trial failing to meet its end points, compelling data ... from future studies. An analyst report on ... financial review, analyst summary, valuation, and recommendation can be ...
(Date:4/30/2015)... , April 30, 2015  Accuray Incorporated ... has signed an agreement with MIM Software Inc. ... TomoTherapy ® and CyberKnife ® product portfolios. ... and MIM technology. This is Accuray,s second collaboration ... development of the first iPad-based treatment plan review ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
... Minimally Invasive Devices, Inc. , (MID) has been ... laparoscopic visualization system.  This certification is mandatory for sale ... The FloShield system provides for an uninterrupted ... the insufflator to defog and deflect debris from the ...
... Chimerix, Inc., a biotechnology company developing orally-available antiviral ... the Board and Chief Scientific Officer, will participate on ... Therapeutics Conference on July 22nd, 2011, 10:30 am ET. ... Club in Washington, D.C. on July 20-22, 2011, and ...
Cached Medicine Technology:Minimally Invasive Devices, Inc. Awarded CE Mark for FloShield™ 2Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 2Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 3
(Date:5/1/2015)... TROY Healthcare Solutions is proud to ... Group (RUG) Conference in Atlanta, GA from May 6 ... Conference provides a forum for client-to-client presentations, continuing education ... of electronic medical record operations, as well as showcasing ... In addition to sponsoring the event, TROY Healthcare Solutions ...
(Date:5/1/2015)... Hope For The Warriors® thanks All American ... Warriors® and military families. All American Ford presented two ... Warriors®, a national nonprofit dedicated to restoring a sense ... for our service members and our military families. , ... and matched small autograph fee from fans and presented ...
(Date:5/1/2015)... The fields of genetics and genomics, the ... genes with one another and the environment, is rapidly ... LabRoots, the premier producer of interactive virtual events for ... its annual conference spotlighting the recent advances in Genetics ... Genomics 2015 , a two-day event presented entirely online ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up campaign announced that ... the rights of adolescent girls in India. This announcement ... Up began almost five years ago – kicks off a ... the Rajasthan region of India. , “For the past ... girls in Guatemala, Ethiopia, Liberia, and Malawi. As we ...
(Date:5/1/2015)... 01, 2015 Digital technology and Wi-Fi-enabled ... women between prenatal appointments, a preliminary study ... small sample of low-risk pregnant women, will be presented ... University Medical Faculty Associates at the 2015 American Congress ... Meeting, May 2-6. The digital technology used was developed ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... one of the most "wired" hospitals in the U.S. ... ... 2008 -- Artromick provides accurate and efficient medication management solutions ... In today's demanding world of health care, hospitals, like Camden-Clark ...
... with tools to lead a healthy ... ... the National Council of La Raza (NCLR) to unveil a small,tool aimed at ... pocket-sized health book, Buena Salud, Buena Vida --,Su Guia de Recursos de Salud, ...
... clinicians, including intelligent innovations that redefine the way women in healthcare ... enhancements, Medelita sets a new standard for quality, comfort, performance and ... alone wearing scrubs and lab coats to work. , ... ...
... Emergency department ,teachable moments, remembered well by parents, youngsters, ... Pediatric trauma centers and emergency departments are good places ... reduce the threat of injury, according to researchers at ... , "We know that children who are admitted to ...
... for antibiotics under the fluoroquinolones drug family that will now require a ... instituted the mandate due to the greater risk of tendonitis and tendon ... ... 2008 -- LegalView, the number one resource for everything legal on the ...
... to the,Senate, forty-five leading human rights and global ... legislation that would,reauthorize the President,s Plan for AIDS ... a five-year, $50 billion HIV/AIDS relief package, the,organizations ... policies based,on evidence gathered and lessons learned after ...
Cached Medicine News:Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 4Health News:Medelita Introduces A Breakthrough In Healthcare Uniforms For Women 2Health News:Medelita Introduces A Breakthrough In Healthcare Uniforms For Women 3Health News:Trauma Center Counseling Reduces Kids' Repeat Injuries 2Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 2Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 3Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 2Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 5
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
Neuropack MEB-2200 evoked potential/EMG measuring system is user friendly Windows NT, Pentium III PC-based EP/EMG measuring system....
... line of Myoquick systemplus Multi-channels Evoked Potential testing ... in the neurophysiology field and shows the extremely ... unit adopt the 32 channels headbox BQ 132S ... ISA 100x EP family headboxes: ISA 1002 EP ...
... 6 popular colors to match any ... to accommodate wheel chair patients and ... and quiet elctro-mechanical up/down movement. Easy ... programmable memory Patient safety impact guard ...
Medicine Products: